CEACAM5 and colorectal carcinoma: recruited 48 patients with resected CRC to compare the specificity and sensitivity of ctDNA surveillance (Signatera) with measurement of CEA levels, imaging, and combination of imaging with CEA levels as suggested by the National Comprehensive Cancer Network guidelines.